Biocon

From Freepedia

Biocon is India's leading biotechnology enterprise. Established in 1978, the company today is an integrated biotechnology enterprise focused on the development of biopharmaceuticals. With successful initiatives in drug discovery and development, bioprocessing and global marketing, the company delivers products and solutions to partners and customers in over 50 countries. Within the biotechnology space, the company ranks first in Asia in terms of revenues and market capitalisation and sixteenth globally.

The company is headed by Kiran Mazumdar-Shaw, India's richest woman. She achieved this status after Biocon went for an IPO in 2004. Biocon became only the second Indian company to cross a market capitalisation of One billion U.S. $ on the first day of listing. Mazumdar-Shaw and her husband John Shaw own over 60% of the company's stock.

Key Facts

• Biocon is India's first biotechnology company, established

in 1978

• Biocon is the country's first biotechnology company to export

microbial enzymes to USA and Europe

• Biocon is the first biotechnology company to receive

ISO 9001 certification in India

• Syngene, a Biocon subsidiary, is the country's first biotech

custom research company in drug discovery

• Biocon is the first Indian company to be approved by US FDA

for the manufacture of lovastatin, a cholesterol-lowering molecule

• Biocon's proprietary bioreactor, the PlaFractor™, has a US

patent

• Biocon's subsidiary, Clinigene, has India's first CAP (College

of American Pathologists) accredited clinical research laboratory, setting a standard for laboratories in India

• Biocon is awarded the Biotech Product and Process

Development and Commercialisation Award 2001 by the Department of Biotechnology, Ministry of Science and Technology, Government of India

• Syngene International is awarded the Certificate of Excellence

for Export Achievement by the Government of India, for two consecutive years 2002-2003

• Biocon is the first company, globally to manufacture

human insulin using a Pichia expression system

• Biocon aims to be the first Indian company to set up production of

monoclonal antibodies

Products

Biopharmaceuticals

• Anti-Diabetic Agents
• Anti-Hypertensive Agents
• Anti-Inflammatory Agents
• Anti-Oxidants
• Cardiovascular Agents
• Digestive Aid Enzymes
• Haemostatic Agents
• Hepatoprotective Agents
• Immunosuppressants
• Nutraceuticals

Enzymes

• Amylases
• Cellulases
• Esterases
• Glucanases
• Hemicellulases/Xylanases
• Oxidases
• Pectinases
• Proteases
• Tannase

Awards

Over the years, Biocon has been conferred with recognition from industry and government. Some of the major awards it received are: -

• National Award for the Best Small Industry (1985)
• Rabo India Bio-Business Award Bio-Entrepreneur (2003)
• Hewitt Best Employer in India Award (2004)
• Best Reinvention of HR Function Award, Indira Group, Mumbai (2004)
• Rotary Award for Corporate Citizenship (2005)

References

• Biocon's official site